Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$45.4B
| $38M | 0.06% |
414,600
+214,600
| +107% | +$19.3M |
|
452
LivaNova
LIVN
$4.34B
| $37.9M | 0.06% |
389,272
+361,346
| +1,294% | +$33.7M |
|
453
Domino's
DPZ
$11.3B
| $37.8M | 0.06% |
146,260
+129,557
| +776% | +$33.7M |
|
454
CareTrust REIT
CTRE
$9.35B
| $37.6M | 0.06% |
1,604,213
-398,765
| -20% | -$8.74M |
|
455
Eastman Chemical
EMN
$8.47B
| $37.6M | 0.06% |
495,779
+431,374
| +670% | +$34.3M |
|
|
APLS
456
DELISTED
Apellis Pharmaceuticals
APLS
| $37.6M | 0.06% |
1,926,566
+744,181
| +63% | +$11.7M |
|
457
VICI Properties
VICI
$29.2B
| $37.5M | 0.06% |
1,713,153
+872,750
| +104% | +$18.4M |
|
458
Bunge Global
BG
$21.7B
| $37.5M | 0.06% |
706,061
-67,251
| -9% | -$3.57M |
|
459
GSK
GSK
$105B
| $37.5M | 0.06% |
716,986
+424,726
| +145% | +$21.2M |
|
460
ServiceNow
NOW
$133B
| $37.4M | 0.06% |
759,465
-413,445
| -35% | -$18.2M |
|
|
SRCI
461
DELISTED
SRC Energy Inc
SRCI
| $37.2M | 0.06% |
7,270,695
+761,923
| +12% | +$3.73M |
|
|
462
Apple
AAPL
$4.51T
| $37.2M | 0.06% |
783,832
-12,337,596
| -94% | -$523M |
|
463
New Oriental
EDU
$8.88B
| $37.2M | 0.06% |
412,754
+384,031
| +1,337% | +$28.9M |
|
|
EXAS
464
DELISTED
Exact Sciences
EXAS
| $37.2M | 0.06% |
429,248
-65,861
| -13% | -$5.61M |
|
465
PUT
Comcast
CMCSA
$95.3B
| $37.2M | 0.06% |
929,700
+479,700
| +107% | +$18M |
|
466
Hexcel
HXL
$7.1B
| $37.2M | 0.06% |
537,397
+517,213
| +2,562% | +$34.8M |
|
|
ARRY
467
DELISTED
Array Biopharma Inc
ARRY
| $37.1M | 0.06% |
1,521,778
-1,477,556
| -49% | -$30.8M |
|
468
Outfront Media
OUT
$5.25B
| $37M | 0.06% |
1,607,159
-365,650
| -19% | -$7.67M |
|
469
Williams-Sonoma
WSM
$28B
| $36.8M | 0.06% |
+1,308,682
| New | +$36.1M |
|
|
DATA
470
DELISTED
Tableau Software, Inc.
DATA
| $36.8M | 0.06% |
288,921
-286,942
| -50% | -$36.2M |
|
471
CALL
SPDR Gold Trust
GLD
$154B
| $36.6M | 0.05% |
300,000
-850,000
| -74% | -$105M |
|
472
United Airlines
UAL
$36.7B
| $36.5M | 0.05% |
458,010
-2,446,425
| -84% | -$206M |
|
473
CALL
Baidu
BIDU
$31.6B
| $36.5M | 0.05% |
+221,300
| New | +$37M |
|
474
Unum
UNM
$13.9B
| $36.3M | 0.05% |
1,073,681
-138,259
| -11% | -$4.81M |
|
475
OGE Energy
OGE
$9.42B
| $36.3M | 0.05% |
842,345
-644,525
| -43% | -$26.7M |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.